Metraipolis › archive › dc_78bbbd2c132d

Adaptive Biomarker-Based Design for Early Phase Clinical Trials — Europe PMC PMID:41066076

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41066076
DOI: 10.1002/sim.70275
License (as archived): solo-consultazione
Archived: 2026-11-09T16:36:00.996Z
SHA-256 of the archived text: 652b1622945ec1a2311799b9613a8bd9fee03109fe3d261b7eb11795010bd09c
Stable URL of this page: https://metraipolis.com/documento/dc_78bbbd2c132d

How to cite

Adaptive Biomarker-Based Design for Early Phase Clinical Trials — Europe PMC PMID:41066076 — Europe PMC (en), https://europepmc.org/article/MED/41066076 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_78bbbd2c132d (Metraipolis archive dc_78bbbd2c132d, sha256 652b1622945ec1a2311799b9613a8bd9fee03109fe3d261b7eb11795010bd09c)

BibTeX

@misc{dc78bbbd2c132d,
  title = {Adaptive Biomarker-Based Design for Early Phase Clinical Trials — Europe PMC PMID:41066076},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41066076},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_78bbbd2c132d; sha256 652b1622945ec1a2311799b9613a8bd9fee03109fe3d261b7eb11795010bd09c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41066076. Agents can read the archived copy with the MCP tool read_document.